Credit Suisse Reinstates Vifor Pharma AG (VIFN:SW) (GNHAY) at Outperform

June 19, 2020 5:42 AM EDT
Get Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 22 | Down: 13 | New: 31
Trade Now! 
Join SI Premium – FREE

Credit Suisse analyst Barbora Blaha reinstates coverage on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) with a Outperform rating and a price target of CHF170.00 (from CHF160.00).

You May Also Be Interested In

Related Categories

Analyst PT Change, Intl Ratings, New Coverage